Complex 3D tissue disease models are being used as surrogates for pre-clinical drug development. However, current methods for fabricating artificial tissues are based on image-derived, or manually designed tissue architectures, and lack high-throughput applicability. This project is developing generative methods for designing bio-printable lung tissues across a spectrum of disease severity in the specific context of mouse and human lung disease.